Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

We report the results from a Foundation for the National Institutes of Health Biomarkers Consortium project to address the absence of well-validated quality control materials (QCMs) for circulating tumor DNA (ctDNA) testing. This absence is considered a cause of variance and inconsistencies in trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, P. Mickey, Forbes, Thomas, P. Lund, Steven, Cole, Kenneth D., He, Hua-Jun, Karlovich, Chris, Paweletz, Cloud P., Stetson, Daniel, Yee, Laura M., Connors, Dana E., Keating, Susan M., Destenaves, Benoit, Cleveland, Megan H., Lau, Christie J., Barrett, J. Carl, Kelloff, Gary J., McCormack, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232894/
https://www.ncbi.nlm.nih.gov/pubmed/34250423
http://dx.doi.org/10.1200/PO.20.00528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232894/
https://www.ncbi.nlm.nih.gov/pubmed/34250423
http://dx.doi.org/10.1200/PO.20.00528

Ejemplares similares